Beranda › Sindrom Bronkiolitis Obliterans › Michigan
Uji klinis Sindrom Bronkiolitis Obliterans di Michigan
7 studi untuk Sindrom Bronkiolitis Obliterans mencari peserta di lokasi di Michigan.
Kota di Michigan
Teks studi resmi (Bahasa Inggris)
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
- University of Michigan, Ann Arbor
- Henry Ford Hospital, Detroit
- Corewell Health Hematology Oncology, Grand Rapids
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT06585774Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
- Corewell Health, Grand Rapids
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT05919511A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
- Barbara Ann Karmanos Cancer Institute, Detroit
Menerima pesertaFase 2
Usia 2 ke atas · Semua jenis kelamin · Diperbarui 16 Jun 2026 · NCT04710576BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
- University of Michigan, Ann Arbor
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Jun 2026 · NCT05922761A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
- University of Michigan, Ann Arbor
- Karmanos Cancer Institute, Detroit
- Henry Ford Hospital, Detroit
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Mei 2026 · NCT06615050Ketamine-assisted Integrative Treatment for Veterans With Chronic Low Back Pain and Comorbid Depression
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Des 2025 · NCT06419439A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- Henry Ford Cancer Institute, Detroit
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Des 2025 · NCT06619561Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.